Market Cap

Bruker Corporation Market Capitalization:

$6.43 Billion

USD as of July 1, 2025

business Bruker Corporation Company Profile

Bruker Corporation Main Stock Listing

NASDAQ: BRKR

Market Capitalization History of Bruker Corporation

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $233.33 B
Boston Scientific Corporation $154.34 B
Stryker $151.06 B
Medtronic $113.25 B
Edwards Lifesciences Corporation $45.05 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Bruker Corporation market cap

Date Market Cap YoY Change
Jan. 1, 2025 $8.82 B -9.44%
Jan. 1, 2024 $9.74 B -6.81%
Jan. 1, 2023 $10.45 B 1.05%
Jan. 1, 2022 $10.34 B 15.05%
Jan. 1, 2021 $8.99 B 17.02%
Jan. 1, 2020 $7.68 B 41.10%
Jan. 1, 2019 $5.45 B -1.54%
Jan. 1, 2018 $5.53 B 50.06%
Jan. 1, 2017 $3.69 B 6.27%
Jan. 1, 2016 $3.47 B 18.40%
Jan. 1, 2015 $2.93 B -7.32%
Jan. 1, 2014 $3.16 B 20.63%
Jan. 1, 2013 $2.62 B 18.72%
Jan. 1, 2012 $2.21 B -18.80%
Jan. 1, 2011 $2.72 B 42.62%
Jan. 1, 2010 $1.91 B 204.47%
Jan. 1, 2009 $625.9 M -60.68%
Jan. 1, 2008 $1.59 B 37.58%
Jan. 1, 2007 $1.16 B 51.42%
Jan. 1, 2006 $764.2 M 36.29%
Jan. 1, 2005 $560.7 M -36.22%
Jan. 1, 2004 $879.1 M 43.29%
Jan. 1, 2003 $613.5 M -72.22%
Jan. 1, 2002 $2.21 B -43.12%
Jan. 1, 2001 $3.88 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Bruker Corporation Categories

United States languages Healthcare languages Medical Devices
United States Healthcare United States Medical Devices

Stocks & Indices

Bruker Corporation has the following listings and related stock indices.


Stock: NASDAQ: BRKR

Stock: FSX: BKD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.